Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+56.7Malignant Bladder Neoplasm+23.3Cutaneous Melanoma+20Malignant Laryngeal Neoplasm+20Malignant Pancreatic Neoplasm+10Malignant Vaginal Neoplasm+10Malignant Vulvar Neoplasm+10Malignant Salivary Gland Neop…+3.3Malignant Kidney Neoplasm+3.3Malignant Mesothelioma+3.3Malignant Ovarian Neoplasm+3.3Malignant Esophageal Neoplasm0Malignant Lung Neoplasm0Malignant Prostate Neoplasm0Malignant Rectal Neoplasm0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+56.7100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
43650
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
96.7
activityPercentile
40

ranking row 2596864

2=Malignant Bladder Neoplasm+23.396.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14036
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
70
activityPercentile
46.7

ranking row 2596865

3=Cutaneous Melanoma+2093.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8623
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
46.7
activityPercentile
26.7

ranking row 2596866

4=Malignant Laryngeal Neoplasm+2090Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3760
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
20

ranking row 2596867

5=Malignant Pancreatic Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
35234
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
90
activityPercentile
80

ranking row 2596868

5=Malignant Vaginal Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
417
formula
percentile(mortality_count) − percentile(active_trials)
activity
31
burdenPercentile
10
activityPercentile
0

ranking row 2596869

5=Malignant Vulvar Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
921
formula
percentile(mortality_count) − percentile(active_trials)
activity
54
burdenPercentile
23.3
activityPercentile
13.3

ranking row 2596870

8=Malignant Salivary Gland Neoplasm+3.376.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
718
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
20
activityPercentile
16.7

ranking row 2596871

9=Malignant Kidney Neoplasm+3.373.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12895
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
60
activityPercentile
56.7

ranking row 2596873

9=Malignant Mesothelioma+3.373.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2538
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
33.3
activityPercentile
30

ranking row 2596872

9=Malignant Ovarian Neoplasm+3.373.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14362
formula
percentile(mortality_count) − percentile(active_trials)
activity
684
burdenPercentile
73.3
activityPercentile
70

ranking row 2596874

12=Malignant Esophageal Neoplasm063.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13714
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
63.3
activityPercentile
63.3

ranking row 2596875

12=Malignant Lung Neoplasm063.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
158592
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2596876

12=Malignant Prostate Neoplasm063.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
28471
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
86.7
activityPercentile
86.7

ranking row 2596877

12=Malignant Rectal Neoplasm063.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9207
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
50
activityPercentile
50

ranking row 2596879

12=Malignant Testicular Neoplasm063.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
358
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
6.7
activityPercentile
6.7

ranking row 2596878

17=Malignant Thyroid Gland Neoplasm-3.346.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1649
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
30
activityPercentile
33.3

ranking row 2596880

18=Malignant Anal Neoplasm-3.343.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
718
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
20
activityPercentile
23.3

ranking row 2596881

19=Malignant Breast Neoplasm-3.440Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
41026
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
93.3
activityPercentile
96.7

ranking row 2596882

20=Malignant Liver Neoplasm-6.636.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
18213
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
76.7
activityPercentile
83.3

ranking row 2596883

21=Malignant Hypopharyngeal Neoplasm-6.733.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
294
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
3.3
activityPercentile
10

ranking row 2596884

21=Malignant Penile Neoplasm-6.733.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
246
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
6.7

ranking row 2596885

23=Leukemia-6.726.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
22431
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
83.3
activityPercentile
90

ranking row 2596886

24=Malignant Central Nervous System Neoplasm-1023.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13724
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
66.7
activityPercentile
76.7

ranking row 2596887

24=Malignant Gastric Neoplasm-1023.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11352
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
56.7
activityPercentile
66.7

ranking row 2596888

26=Hodgkin Lymphoma-1016.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1171
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
26.7
activityPercentile
36.7

ranking row 2596889

27=Non-Hodgkin Lymphoma-13.313.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
20368
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
80
activityPercentile
93.3

ranking row 2596890

28=Malignant Uterine Corpus Neoplasm-16.610Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3436
formula
percentile(mortality_count) − percentile(active_trials)
activity
411
burdenPercentile
36.7
activityPercentile
53.3

ranking row 2596891

29=Malignant Cervical Neoplasm-16.76.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4008
formula
percentile(mortality_count) − percentile(active_trials)
activity
505
burdenPercentile
43.3
activityPercentile
60

ranking row 2596892

30=Multiple Myeloma-203.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10606
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
53.3
activityPercentile
73.3

ranking row 2596893

31=Malignant Nasopharyngeal Neoplasm-300Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
645
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
13.3
activityPercentile
43.3

ranking row 2596894

Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash b6e71f1af1198e69bba14891